Healthcare provider profile · identity verified

Itoro Bassey Edet Daniels, MD

Internal Medicine · GREENSBORO, GA · NPI 1508202995

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	366	118
Amlodipine Besylate	Amlodipine Besylate	353	118
Gabapentin	Gabapentin	208	60
Hydrochlorothiazide	Hydrochlorothiazide	177	55
Furosemide	Furosemide	155	57
Potassium Chloride	Potassium Chloride	154	56
Losartan Potassium	Losartan Potassium	140	38
Albuterol Sulfate Hfa	Albuterol Sulfate	137	48
Tramadol Hcl	Tramadol Hcl	137	43
Lisinopril	Lisinopril	123	45
Ozempic	Semaglutide	119	31
Alprazolam	Alprazolam	117	19
Omeprazole	Omeprazole	113	43
Metoprolol Succinate	Metoprolol Succinate	110	32
Mounjaro	Tirzepatide	110	23
Levothyroxine Sodium	Levothyroxine Sodium	102	33
Metformin Hcl	Metformin Hcl	99	32
Pantoprazole Sodium	Pantoprazole Sodium	93	37
Zolpidem Tartrate	Zolpidem Tartrate	88	15
Fluticasone Propionate	Fluticasone Propionate	84	42
Meloxicam	Meloxicam	84	30
Linzess	Linaclotide	79	24
Metoprolol Tartrate	Metoprolol Tartrate	78	27
Famotidine	Famotidine	77	25
Simvastatin	Simvastatin	77	27
Pregabalin	Pregabalin	75	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	35
Alendronate Sodium	Alendronate Sodium	70	20
Allopurinol	Allopurinol	70	26
Rosuvastatin Calcium	Rosuvastatin Calcium	69	22
Sertraline Hcl	Sertraline Hcl	68	17
Carvedilol	Carvedilol	65	20
Trazodone Hcl	Trazodone Hcl	64	27
Januvia	Sitagliptin Phosphate	63	18
Pravastatin Sodium	Pravastatin Sodium	62	18
Clonidine Hcl	Clonidine Hcl	54	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	11
Montelukast Sodium	Montelukast Sodium	52	18
Clopidogrel	Clopidogrel Bisulfate	51	15
Clonazepam	Clonazepam	50	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	18
Prednisone	Prednisone	49	25
Citalopram Hbr	Citalopram Hydrobromide	48	13
Diclofenac Sodium	Diclofenac Sodium	47	24
Glimepiride	Glimepiride	47	15
Cyproheptadine Hcl	Cyproheptadine Hcl	43	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	14
Duloxetine Hcl	Duloxetine Hcl	42	11
Symbicort	Budesonide/Formoterol Fumarate	39	13
Amoxicillin	Amoxicillin	38	31
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	11
Metformin Hcl Er	Metformin Hcl	37	13
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Azithromycin	Azithromycin	36	28
Fluconazole	Fluconazole	36	22
Chlorthalidone	Chlorthalidone	33	suppressed
Glipizide	Glipizide	32	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Ibuprofen	Ibuprofen	31	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Ondansetron Odt	Ondansetron	30	15
Triamcinolone Acetonide	Triamcinolone Acetonide	30	19
Colchicine	Colchicine	29	11
Hydralazine Hcl	Hydralazine Hcl	29	12
Methylprednisolone	Methylprednisolone	29	21
Promethazine Hcl	Promethazine Hcl	29	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	29	15
Valacyclovir	Valacyclovir Hcl	29	suppressed
Calcitriol	Calcitriol	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Latanoprost	Latanoprost	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	22
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Valsartan	Valsartan	26	suppressed
Levemir Flexpen	Insulin Detemir	25	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	24
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Cephalexin	Cephalexin	24	15
Gemfibrozil	Gemfibrozil	24	suppressed
Levofloxacin	Levofloxacin	24	20
Topiramate	Topiramate	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Eliquis	Apixaban	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Atenolol	Atenolol	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	13
Irbesartan	Irbesartan	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Humalog	Insulin Lispro	20	suppressed
Glyburide	Glyburide	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Nystatin	Nystatin	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Cefdinir	Cefdinir	13	13
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Testosterone	Testosterone	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methimazole	Methimazole	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Naproxen	Naproxen	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error